Potential Alzheimer’s therapy

More from this show

The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer’s disease. The five-year grant will fund a national clinical trial to determine whether alloprognanalone, or allo, is an effective treatment for those with early-stage Alzheimer’s who have a genetic risk for the disease. We hear more from Roberta Diaz Brinton, director of the Center for Innovation in Brain Science.

Roberta Diaz Brinton, director of the Center for Innovation in Brain Science

Pavlo: Live in Santorini
airs Dec. 3

Don’t miss ‘Pavlo: Live in Santorini’

aired Nov. 28

Stewart Udall: The Politics of Beauty

Proposal for Phoenix Latino Cultural Center

Don’t miss ‘Horizonte’ Saturdays at 6 p.m.

Our Voices: August Wood on preserving cultural artisan traditions

August Wood on preserving cultural artisan traditions

Subscribe to Arizona PBS Newsletters

STAY in touch
with azpbs.org!

Subscribe to Arizona PBS Newsletters: